QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
City of Industry, CA -- (SBWIRE) -- 08/17/2018 -- This report studies the global dPCR market status and forecast, categorizes the global dPCR market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Digital polymerase chain reaction (dPCR) technology is an advanced version of the polymerase chain reaction (PCR) technology that enables users to amplify and directly quantify nucleic acids, such as DNA, RNA, cDNA, and methylated DNA with a high level of precision. The technique allows users to statistically analyze PCR products by converting exponential, analog signals obtained from conventional PCR technology to linear and digital signals.
One of the primary drivers for this market is the rise in the focus on disease diagnosis and drug discovery and development. This increase in focus on medical research and drug discovery and development of several diseases is mainly driven by pharmaceutical and biotechnology companies as well as by research institutes. Also, it has been observed that governments of many developed and developing countries have been supporting research for new drug discovery and development. dPCR technology plays a vital role in drug discovery and development and for gene expression profiling, nucleic acid sequencing, and pharmacogenomics. Consequently, the major pharmaceutical and biotechnology companies will increase their adoption of dPCR technology due to high specificity, high accuracy, and productive results in developing new drug candidates. Such factors are expected to propel growth in the global dPCR market during the forecast period.
The global dPCR market is largely fragmented with the presence of many international and regional players present across the globe. The demand for dPCR solutions will be high in emerging countries, especially the BRIC countries (Brazil, Russia, India, China, and South Africa), due to an increase in their investments in drug research activities in various fields, including diagnosis of cancer. This rise is expected to intensify the competition among vendors in the next few years.
The major players covered in this report
Bio-Rad Laboratories
Fluidigm
RainDance Technologies
Thermo Fisher Scientific
Becton
Dickinson and Company
Exiqon
Formulatrix
Promega Corporation
Sigma-Aldrich
Stilla Technologies
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/627576/global-dpcr-sales-market
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/1a79b35ce60128c03b687cfbf2734193,0,1
About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.